1 of 1
Story summary
- BASF is holding exploratory talks with Evonik about a potential takeover.
- BASF confirmed on 25 September it is discussing a public offer with Evonik and RAG-Stiftung.
- Evonik will cut 3,200 jobs and close Hamburg by mid-2027 and Bitterfeld in April 2027.
- Evonik will invest €93 million in a GMP drug facility in Vancouver with €42 million Canadian support.
- Evonik allocated €80 million to add fermentation capacity for APIs at its Slovak site.